Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1467671792
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8901 Carti Way
Little Rock, AR, 72205
Phone (501) 906-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.0M
288,575 services
Medicare patients, 2024
1,374
Average age 75
Drug cost, 2024
$9.9M
7,945 prescriptions
Company payments, 2025
$13.56
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Omer Khalil was code Q5125 (injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram), 31,500 times for 24 patients. In total Omer Khalil billed 288,575 services in 216 codes, and Medicare paid $5.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 31,500 | 24 | $0.38 | $12K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 26,000 | 42 | $44.76 | $1.2M |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 20,400 | 18 | $0.27 | $5,430 |
| J0896 Injection, luspatercept-aamt, 0.25 mg | Office | 15,140 | 12 | $31.53 | $477K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 13,500 | 107 | $15.64 | $211K |
| J9299 Injection, nivolumab, 1 mg | Office | 13,240 | 17 | $24.48 | $324K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 11,690 | 85 | $6.30 | $74K |
| J0897 Injection, denosumab, 1 mg | Office | 10,320 | 56 | $20.42 | $211K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 8,300 | 14 | $0.06 | $465 |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,834 | 20 | $0.08 | $628 |
| J0185 Injection, aprepitant, 1 mg | Office | 6,890 | 28 | $1.34 | $9,257 |
| 85025 Blood Count | Office | 5,063 | 940 | $7.58 | $38K |
| 36415 Venipuncture Blood Collection | Office | 4,962 | 955 | $8.64 | $43K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,366 | 138 | $0.09 | $393 |
| J0894 Injection, decitabine, 1 mg | Office | 3,550 | 12 | $1.26 | $4,475 |
By year: 2022 $4.3M for 418,837 services; 2023 $4.3M for 290,794 services; 2024 $5.0M for 288,575 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 5,063 | 940 | $7.58 | $38K |
| 36415 Venipuncture Blood Collection | 4,962 | 955 | $8.64 | $43K |
| 80053 Clinical Chemistry | 2,832 | 893 | $10.32 | $29K |
| 82728 Clinical Chemistry | 1,564 | 566 | $13.33 | $21K |
| 82784 Immunoassay | 534 | 78 | $9.00 | $4,806 |
| 88185 Surgical Pathology Examination | 529 | 22 | $15.88 | $8,401 |
| 83883 Clinical Chemistry | 172 | 73 | $13.17 | $2,265 |
| 84165 Clinical Chemistry | 165 | 79 | $10.42 | $1,720 |
| 83735 Clinical Chemistry | 162 | 38 | $6.57 | $1,064 |
| 82378 Clinical Chemistry | 161 | 75 | $18.58 | $2,991 |
Medicare prescription drug claims, 2024
In 2024, the drug Omer Khalil prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 359 prescriptions and refills. In total Omer Khalil wrote 7,945 Medicare prescriptions that cost $9.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 359 | 359 | 78 | $11K |
| Pantoprazole Sodium Generic | 338 | 494 | 75 | $2,858 |
| Oxycodone Hcl Generic | 282 | 282 | 31 | $7,957 |
| Amlodipine Besylate Generic | 184 | 352 | 47 | $756 |
| Prednisone Generic | 174 | 234 | 54 | $720 |
| Potassium Chloride Generic | 170 | 263 | 42 | $2,765 |
| Eliquis Apixaban | 160 | 194 | 32 | $112K |
| Lorazepam Generic | 156 | 157 | 28 | $713 |
| Gabapentin Generic | 155 | 203 | 41 | $1,949 |
| Procrit Epoetin Alfa | 147 | 148 | 32 | $418K |
| Ondansetron Hcl Generic | 143 | 143 | 71 | $1,292 |
| Zolpidem Tartrate Generic | 133 | 143 | 24 | $616 |
| Anastrozole Generic | 131 | 189 | 24 | $1,873 |
| Folic Acid Generic | 116 | 185 | 25 | $452 |
| Letrozole Generic | 113 | 156 | 19 | $1,600 |
Brand drugs: - claims; generic drugs: 6,269 claims; opioid claims: 898.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Omer Khalil $13.56 ($13.56 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $13.56.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $13.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.